We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Machine Learning Analyzes MRI Data to Predict Brain Tumor Progression

By HospiMedica International staff writers
Posted on 17 Jan 2023

Glioblastoma multiforme (GBM), a brain cancer that has an average survival rate of just one year, can be difficult to treat because of its highly dense core, rapid growth, and location. More...

Clinicians find it difficult to quickly and accurately estimate the diffusivity and proliferation rate for these tumors in an individual patient. Now, researchers have created a computational model that uses MRI data to predict the growth of these deadly brain tumors more accurately.

Researchers at the University of Waterloo (Waterloo, ON, Canada) analyzed MRI data from several sufferers of GBM using machine learning in order to better predict the progression of cancer. The team analyzed two sets of MRIs from each of five GBM patients who underwent extensive MRIs, waited for months, and then received another set of MRIs. Since these patients opted not to receive any treatment or intervention during this time, the researchers were provided a unique opportunity to examine how GBM grows when left unchecked by analyzing their MRIs.

Using a deep learning model, the researchers turned the MRI data into patient-specific parameter estimates that inform a predictive model for GBM growth. They applied this technique to the patients’ and synthetic tumors, for which the true characteristics were known, allowing them to validate the model. The scientists now have a good model of how GBM grows untreated and will now expand the model to include the impact of treatment on the tumors. The data set would then grow from a handful of MRIs to thousands. According to the researchers, access to MRI data – and partnership between mathematicians and clinicians – can significantly impact patients in the future.

“The integration of quantitative analysis into healthcare is the future,” said Cameron Meaney, a PhD candidate in Applied Mathematics and the study’s lead researcher.


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Cardiograph Device
PageWriter TC35
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.